日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

更正:Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients

肺黏膜相关淋巴组织淋巴瘤的治疗和预后:一项纳入186例患者的多中心分析

Suzuki, Kazutaka; Miyazaki, Kana; Asano, Naoko; Takahashi, Hiroyuki; Koba, Yusuke; Hiramoto, Nobuhiro; Choi, Ilseung; Arima, Hiroshi; Uchida, Toshiki; Nakamura, Nobuhiko; Tatetsu, Hiro; Uryu, Hideki; Ito, Shunsuke; Kato, Takeharu; Sasaki, Hirokazu; Murayama, Tohru; Hiraga, Junji; Takahashi, Naoki; Kobayashi, Tetsu; Takao, Motoshi; Tawara, Isao; Yamaguchi, Motoko

Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial

日本一线ATRA-ATO疗法治疗急性早幼粒细胞白血病:前瞻性多中心FBMTG-APL2017试验结果

Takase, Ken; Kamimura, Tomohiko; Kuriyama, Takuro; Tokuyama, Takahito; Henzan, Hideho; Kikushige, Yoshikane; Choi, Ilseung; Imamura, Yutaka; Mori, Akio; Ohya, Shuki; Kawano, Noriaki; Yonemoto, Koji; Harada, Mine; Akashi, Koichi; Miyamoto, Toshihiro

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study

新诊断的CD5阳性弥漫性大B细胞淋巴瘤的治疗和预后:一项多中心观察性研究

Nato, Yuma; Miyazaki, Kana; Maruyama, Dai; Takahashi, Hiroyuki; Sunami, Kazutaka; Murakami, Satsuki; Negoro, Eiju; Miyazawa, Yuri; Choi, Ilseung; Okada, Takahiro; Takayama, Nobuyuki; Tomita, Naoto; Momose, Shuji; Kaneda, Yuto; Yoshida, Masahiro; Gomyo, Hiroshi; Toyama, Kohtaro; Nishikori, Momoko; Saito, Akio; Hiraga, Junji; Masunari, Taro; Takahashi, Naoki; Makiyama, Junya; Suzuki, Tomotaka; Tsunemine, Hiroko; Takizawa, Jun; Kato, Takeharu; Masaki, Yasufumi; Fukuhara, Noriko; Okamoto, Masataka; Tawara, Isao; Asano, Naoko; Ohshima, Koichi; Izutsu, Koji; Kato, Koji; Suzuki, Ritsuro; Yamaguchi, Motoko

A Multicenter Real-World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30-Positive Adult T-Cell Leukemia-Lymphoma

一项多中心真实世界回顾性研究,评估布伦妥昔单抗、环磷酰胺、多柔比星和泼尼松龙联合治疗既往未接受治疗的CD30阳性成人T细胞白血病/淋巴瘤患者的疗效。

Tokunaga, Masahito; Makiyama, Junya; Shiratsuchi, Motoaki; Toyama, Takanori; Oka, Satoshi; Choi, Ilseung; Yoshida, Takahiro; Okazuka, Kiyoshi; Utsunomiya, Atae

Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma

可溶性免疫检查点分子水平升高在侵袭性成人T细胞白血病-淋巴瘤患者中的临床意义

Fuji, Shigeo; Makiyama, Junya; Takano, Kuniko; Choi, Ilseung; Suzuki, Takeo; Suminaka, Chihiro; Kuroishi, Mao; Iwasaki, Yosuke; Kasahara, Hidenori; Tada, Yuma; Shingai, Yasuhiro; Yuda, Sayako; Yokota, Takafumi; Ishikawa, Jun

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results

妥昔诺司他治疗复发或难治性外周T细胞淋巴瘤患者的长期疗效和安全性:IIb期最终分析结果

Rai, Shinya; Kim, Won Seog; Ando, Kiyoshi; Choi, Ilseung; Izutsu, Koji; Tsukamoto, Norifumi; Maruyama, Dai; Tsukasaki, Kunihiro; Kuroda, Junya; Ando, Jun; Hidaka, Michihiro; Koh, Youngil; Kato, Hisashi; Uchida, Toshiki; Yang, Deok Hwan; Ishitsuka, Kenji; Ishizawa, Kenichi; Kim, Jin Seok; Lee, Hong Ghi; Minami, Hironobu; Eom, Hyeon Seok; Kurosawa, Mitsutoshi; Lee, Jae Hoon; Lee, Jong Seok; Lee, Won Sik; Nagai, Hirokazu; Shindo, Takero; Yoon, Dok Hyun; Yoshida, Shinichiro; Gillings, Mireille; Onogi, Hiroshi; Tobinai, Kensei

Annual Sickle Cell & Thalassaemia Conference (ASCAT) ‐ October 2024

年度镰状细胞和地中海贫血症会议(ASCAT)——2024年10月

Muranushi, Hiroyuki; Shindo, Takero; Hishizawa, Masakatsu; Tokunaga, Masahito; Wake, Atsushi; Nakano, Nobuaki; Eto, Tetsuya; Hidaka, Michihiro; Choi, Ilseung; Miyamoto, Toshihiro; Uchida, Naoyuki; Moriuchi, Yukiyoshi; Miyazaki, Yasuhiko; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kato, Koji

Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion

种族和民族数据细分:迈向多元化、公平和包容的一步

Liang, Peter S; Kwon, Simona C; Cho, Ilseung; Trinh-Shevrin, Chau; Yi, Stella